Japan Tobacco Inc (2914.T)
30 Aug 2016
TOKYO Marlboro maker Philip Morris International says its e-cigarette has rapidly captured close to 3 percent of Japanese tobacco sales, making inroads into a market Japan Tobacco (JT) relies on for 40 percent of its profit.
* PMI says e-cigarette has 2.7 pct share in Japan tobacco market
BRIEF-Menlo Therapeutics signs license agreement with Japan Tobacco, Torii Pharma for NK-1 receptor antagonist
* Menlo Therapeutics signs exclusive license agreement with Japan Tobacco and Torii Pharmaceuticals for development and commercialization of NK-1 receptor antagonist in Japan
* Says it got 40 percent stake in National Tobacco Enterprise Ethiopia S.C from Ethiopian government for $510 million
* Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA"
TOKYO, May 20 Japan's Nikkei was mostly flat on Friday morning as investors stayed on the sidelines ahead of Group of Seven meetings, and prospects for a U.S. interest rate hike as early as June curbed buyers' appetite.
April 8 Japan Tobacco Inc says: - to issue $750 mln in U.S.-denominated 5-year bonds Further company coverage:
Earnings vs. Estimates
Analyst Research Reports
Japan Tobacco Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider : Reuters Investment Profile
Provider : GlobalData
Provider : MarketLine
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.